II
AZN icon

Inspire Investing’s AstraZeneca AZN Stock Holding History

Inspire Investing’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.77K Hold
14
– – ﹤0.01% 996
2025
Q4 		$2.56K Buy
+14
New +$2.46K ﹤0.01% 978
2021
Q3 		– Sell
-18,558
Closed -$2.22M – 807
2021
Q2 		$2.22M Buy
+18,558
New +$2.04M 0.29% 74

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Inspire Investing's AZN Position: Q1 2026 in Review

Inspire Investing held its AstraZeneca (AZN) position steady in Q1 2026 at 14 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Inspire Investing first reported a position in AZN in Q2 2021 and has held it in 3 quarters since. The position peaked at $2.22M in Q2 2021. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Inspire Investing held 14 shares of AstraZeneca worth $2.77K as of Q1 2026.
  • Inspire Investing left its AstraZeneca share count unchanged in Q1 2026.
  • AstraZeneca made up ﹤0.01% of Inspire Investing's portfolio in Q1 2026, its #996 holding.
  • Inspire Investing first reported a position in AstraZeneca in Q2 2021 and has held it in 3 quarters since.
  • Inspire Investing's AstraZeneca position peaked at $2.22M in Q2 2021.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.